Efficacy of Nabiximols in Reducing Pain and Spasticity in Primary Progressive Multiple Sclerosis

Martinelli Bonesch, Filippo (2021) Efficacy of Nabiximols in Reducing Pain and Spasticity in Primary Progressive Multiple Sclerosis. European Journal of Case Reports in Internal Medicine, 8 (Sup 2). pp. 28-29. ISSN 2284-2594

[img]
Preview
Text
efficacy.pdf

Download (190kB) | Preview
Official URL: https://www.ejcrim.com/index.php/EJCRIM/article/vi...

Abstract

Spasticity and its related symptoms, such as muscle stiffness, spasms and pain, are present in 60% of multiple sclerosis patients. We present the case of a 66-year-old woman with a benign form of primary progressive multiple sclerosis who had symptoms of spasticity, leg weakness and pain at disease onset. After 10 years of disease and insufficient response to antispastic and pain drugs, she was started on nabiximols oromucosal spray with good efficacy, safety and tolerability. The patient is now treated with 4 puffs per day and, after 6 years, the drug is still effective in relieving pain and improving sleep.

Item Type: Article
Uncontrolled Keywords: Nabiximols, multiple sclerosis, pain, spasticity, case report
Subjects: 600 Tecnologia - Scienze applicate
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici)
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale)
Depositing User: Marina Spanti
Date Deposited: 19 Jan 2022 17:10
Last Modified: 19 Jan 2022 17:10
URI: http://eprints.bice.rm.cnr.it/id/eprint/21478

Actions (login required)

View Item View Item